Isolating and Mitigating Sequentially Dependent Perceptual Errors in Clinical Visual Search
Launched by UNIVERSITY OF CALIFORNIA, BERKELEY · Mar 31, 2020
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how radiologists—doctors who specialize in reading x-rays—make decisions about tumors based on their past experiences with previous x-rays. Researchers have found that sometimes, what a radiologist sees in one image can be influenced by what they looked at before, which can lead to mistakes in identifying or classifying tumors. The goal of the trial is to understand these influences better and find ways to reduce their impact, ultimately improving how accurately radiologists can detect and assess tumors.
To participate in this trial, you need to be between the ages of 65 and 74 and have normal vision or vision corrected with glasses or contacts. Unfortunately, if you are under 18 or if you are blind, you cannot take part in this study. If you join, you can expect to help researchers figure out how to make x-ray evaluations more reliable, and your involvement could lead to better health outcomes for patients everywhere.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subjects must have normal or corrected to normal vision with contacts or glasses.
- Exclusion Criteria:
- • Subjects may not be under the age of 18 to participate.
- • Subjects may not participate if they are blind.
About University Of California, Berkeley
The University of California, Berkeley, a leading research institution renowned for its commitment to scientific innovation and academic excellence, serves as a prominent sponsor of clinical trials aimed at advancing medical knowledge and improving patient outcomes. With a robust infrastructure for interdisciplinary collaboration, UC Berkeley leverages its distinguished faculty, cutting-edge laboratories, and extensive resources to conduct research that addresses critical health challenges. The university is dedicated to fostering a culture of ethical research practices and ensuring the highest standards of safety and efficacy in its clinical investigations, ultimately contributing to the translation of scientific discoveries into tangible health solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Berkeley, California, United States
Patients applied
Trial Officials
David Whitney, PhD
Principal Investigator
University of California, Berkeley
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials